ABEONA THERAPEUTICS INC.ABEO

Market cap

$255.78M

P/E ratio

	2011/12	2012/12	2013/12	2014/12	2015/12	2016/12	2017/12	2018/12	2019/12	2020/12	2021/12	2022/12	2023/12	2024/12
Depreciation & amortization	233,000	419,000	3,000	11,000	551,000	825,000	741,000	2	8	5	3	3	2	2
Stock-based compensation	1	390,000	439,000	1	4	5	5	8	7	6	5	3	5	7
Cash from operations	-7,609,000	-3,955,000	1,000	-1,611,000	-10,423,000	-13,014,000	-22,935,000	-39,111,000	-62,820,000	-35,019,000	-66	-43	-37	-56
Capital expenditures	-40,000	-13,000	-2,000	-	-308,000	-519,000	-860,000	-9,243,000	-6,309,000	-1,336,000	-4,151,000	-0	-0	-2
Cash from investing	-40,000	-13,000	-2,000	-	3	-519,000	-860,000	-85,086,000	60	-83,714,000	66	-24	0	-39
Proceeds from issuance of term debt, net	-	-	-	-	-	-	-	-	-	-	-	-	-	20
Cash from financing	3	2	29,000	13	36	43	92	5	114	2	25	43	37	104
Free cash flow
FCF margin (%)									-					-